PT-141–11mg
PT-141–11 mg
PT-141 is a synthetic heptapeptide derived from alpha-melanocyte-stimulating hormone (alpha-MSH) functioning as a melanocortin receptor (MCR) agonist. It is designed to function as a pro-sexual agent for the generalised hypoactive sexual desire disorder (HSDD) in premenopausal women.
Original price was: $48.00.$40.00Current price is: $40.00.
Guaranteed Safe Checkout
Features & Compatibility
Product Summary – Pt 141 nasal spray 11mg
| Field | Details |
| Product Name | Pt 141 nasal spray |
| Category | Synthetic peptide; melanocortin receptor (MC1R & MC4R) agonist. |
| Length | 7 amino acids (cyclic heptapeptide analog of α-MSH) |
| Amino Acid Sequence | Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys] -OH (cyclic lactam structure; N-terminal acetylation and D-Phe substitution improves stability) |
| Molecular Formula | C₅₀H₆₈N₁₄O₁₀ |
| Molecular Weight | ≈ 1025.2 Da |
| Form & Purity | Lyophilised powder or pre-filled auto-injector; ≥95% purity (HPLC, vendor spec). |
| Storage | Store at controlled room temperature (20–25 °C) in original packaging; protect from light. Do not freeze. |
| Key Mechanisms | – Activates central melanocortin receptors (MC3R/MC4R) in the hypothalamus → increases dopaminergic signaling linked to sexual desire
– Unlike PDE5 inhibitors, it acts via CNS pathways rather than vascular nitric oxide pathways – Improves sexual desire and reduces distress in HSDD |
| Research / Clinical Use Cases | – Approved: HSDD in premenopausal women (FDA 2019)
– Investigational: Male erectile dysfunction (shown efficacy independent of nitric oxide), antidepressant-induced sexual dysfunction, potential metabolic roles |
| Common AEs / Safety Signals | – Nausea, flushing, headache, vomiting, injection-site reactions
– Temporary increase in blood pressure and decrease in heart rate; contraindicated in uncontrolled hypertension or cardiovascular disease – Hyperpigmentation of skin and gums with chronic use (due to MC1R activation) |
| Contraindications / Warnings | – Pregnancy (category not established; avoid use)
– Uncontrolled hypertension, known cardiovascular disease – Caution in patients with a risk of syncope or those prone to nausea/vomiting |
| Regulatory / Compliance | – FDA approved (2019, brand Vyleesi®) for premenopausal women with HSDD
– Not approved for men (though studied in ED) – Prescription-only; limited to specific indications |
Mechanism of Action Pt 141 nasal spray
PT-141 is a non-selective receptor agonist, but its functional potency is biased towards the MC4R, which is the principal subtype of MCR implicated in prosexual effects. Pt 141 nasal spray binds to MC4R and activates it, triggering the intracellular signalling cascades. [1]
Sexual Health Effects
Preclinical and translational data describe the localised action of Pt 141 nasal spray in the specific CNS areas, including the medial preoptic area (mPOA) and components of the mesolimbic reward system that regulate sexual motivation and behaviour. Animal data explain that PT-141 activates the neurones in the hypothalamus to enhance the dopamine release, which in turn hypothetically improves the sexual motivation.
The MCR signalling, triggered by PT-141, also interacts with other neurotransmitters, such as nitric oxide signalling, which has a role in genital vasodilation and erection. Preclinical studies found that PT-141 caused the cross-talk of serotonergic and glutamatergic, which led to a change in the excitatory/inhibitory balance between the sexual motivational network.
PT-141 acts centrally and modulates the autonomic output to enhance the parasympathetic outflow and NO synthase activity in the cavernosal efferent pathways. Animal models describe the ability of Pt 141 nasal spray to produce an erection and show synergistic effects when combined with a peripheral agent like a PDE-5 inhibitor. [3]
Latest Research on HSDD & Pt 141 nasal spray
Most recent evidence shows that Pt 141 nasal spray supports boosting sexual desire and reducing issues in women with HSDD. Brain scans strengthen that it affects how the brain processes sexual signals. But not everyone agrees that the data is substantial; some reports note missing information, higher side effects, and lower long-term preference for the drug. [4]
Tolerability and Safety Considerations of Pt 141 nasal spray
- Generally well tolerated in approved use
- The most common adverse events can be nausea, flushing, headache, and a transient increase in blood pressure.
- Contraindicated in patients with uncontrolled hypertension or cardiovascular disease.
- No significant risk of skin cancer was observed (unlike some other melanocortin analogues), but long-term data remain limited.
- FDA-approved; safety established mainly in short-term, on-demand dosing.
Additional information
Customer Reviews
Related Products
Reviews
There are no reviews yet.